83
Participants
Start Date
September 30, 2009
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Erythropoietin
40.000 IU/ml epoetin alfa is administered as intravenous infusions over 15 min weekly for 8 weeks.
Copenhagen University Hospital, Rigshospitalet, Copenhagen
Collaborators (1)
The Ministry of Science, Technology and Innovation, Denmark
OTHER_GOV
Novo Nordisk A/S
INDUSTRY
University of Oxford
OTHER
Max-Planck-Institute of Experimental Medicine
OTHER
Lars Vedel Kessing, professor, MD, DMSc.
OTHER